Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
6.37
-0.34 (-5.07%)
At close: Jul 14, 2026, 4:00 PM EDT
6.44
+0.07 (1.10%)
After-hours: Jul 14, 2026, 6:27 PM EDT
ARCT Market Cap
ARCT has a market cap or net worth of $181.05 million as of July 14, 2026. Its market cap has decreased by -49.92% in one year.
Market Cap
181.05M
Enterprise Value
-3.49M
1-Year Change
-49.92%
Ranking
Category
Stock Price
$6.37
Market Cap Chart
Since May 22, 2013, ARCT's market cap has increased from $103.00M to $181.05M, an increase of 75.78%. That is a compound annual growth rate of 4.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 181.05M | 3.94% |
| Dec 31, 2025 | 174.20M | -62.11% |
| Dec 31, 2024 | 459.70M | -45.44% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 138.35% |
| May 22, 2013 | 103.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 193.87M |
| Protalix BioTherapeutics | 192.57M |
| Korro Bio | 188.94M |
| Tiziana Life Sciences | 187.50M |
| Cibus | 186.25M |
| MediWound | 184.69M |
| Tenaya Therapeutics | 184.56M |
| Canton Strategic Holdings | 182.78M |